Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Asıl Yazarlar: | Davies, KE, Chamberlain, JS |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer Nature
2019
|
Benzer Materyaller
-
Therapeutic approaches to muscular dystrophy.
Yazar:: Goyenvalle, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
Yazar:: Guiraud, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
Yazar:: Fairclough, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Progress in therapy for Duchenne muscular dystrophy
Yazar:: Fairclough, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
Yazar:: Potter, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)